Brian Gallagher

Brian Gallagher has made 68 investments in companies such as: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin, CRISPR Therapeutics, Attenua, Broncus Technologies, Jasper Therapeutics, Synosia Therapeutics, X4 Pharmaceuticals, Kspine, Zogenix, PrimeraDx (Primera Biosystems), Scorpion Therapeutics, Avila Therapeutics, Personalis, MD On-Line, GenSight Biologics, Dicerna Pharmaceuticals, Verona Pharma, Micromet, Proteon Therapeutics, Prosensa, Stanmore Implants Worldwide, GTx, Median Technologies, Valeritas, Soleno Therapeutics, Wilson Therapeutics, Chroma Therapeutics, Avillion, Hydra Biosciences, Algeta, Sientra, Intellikine, Chiasma, Gynesonics, Reneo Pharmaceuticals, Vera Therapeutics, Portola Pharmaceuticals, Nouscom, Vaxcyte, Lombard Medical plc, Labcyte, Pathwork Diagnostics, Senseonics, Novexel, Clovis Oncology, Atsena Therapeutics, Cytos, VirionHealth, Phathom Pharmaceuticals, Fovea Pharmaceuticals, Venatorx Pharmaceuticals, IS Pharma, Effector Therapeutics, Sonitus Medical, Paratek Pharmaceuticals, Q32 Bio, GammaDelta Therapeutics, Tizona Therapeutics, Oxagen, SFJ Pharmaceuticals, Avedro, IFM Therapeutics, Virion Biotherapeutics, Realm Therapeutics, Pixium Vision.

Location of Brian Gallagher is Boston, United States.

The free version of Angel Match provides limited data for Brian Gallagher. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.


Brian Gallagher is a Partner and he his investment types are: Venture Capital.
Brian Gallagher focuses investing in industries such as: Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics, Life Science, Medical, Medical Device, Women Founded.

A short brief about investor:

About

Past investments

  • Kesios Therapeutics
  • Spruce Biosciences
  • Amarin
  • Syntaxin
  • CRISPR Therapeutics
  • Attenua
  • Broncus Technologies
  • Jasper Therapeutics
  • Synosia Therapeutics
  • X4 Pharmaceuticals
  • Kspine
  • Zogenix
  • PrimeraDx (Primera Biosystems)
  • Scorpion Therapeutics
  • Avila Therapeutics
  • Personalis
  • MD On-Line
  • GenSight Biologics
  • Dicerna Pharmaceuticals
  • Verona Pharma
  • Micromet
  • Proteon Therapeutics
  • Prosensa
  • Stanmore Implants Worldwide
  • GTx
  • Median Technologies
  • Valeritas
  • Soleno Therapeutics
  • Wilson Therapeutics
  • Chroma Therapeutics
  • Avillion
  • Hydra Biosciences
  • Algeta
  • Sientra
  • Intellikine
  • Chiasma
  • Gynesonics
  • Reneo Pharmaceuticals
  • Vera Therapeutics
  • Portola Pharmaceuticals
  • Nouscom
  • Vaxcyte
  • Lombard Medical plc
  • Labcyte
  • Pathwork Diagnostics
  • Senseonics
  • Novexel
  • Clovis Oncology
  • Atsena Therapeutics
  • Cytos
  • VirionHealth
  • Phathom Pharmaceuticals
  • Fovea Pharmaceuticals
  • Venatorx Pharmaceuticals
  • IS Pharma
  • Effector Therapeutics
  • Sonitus Medical
  • Paratek Pharmaceuticals
  • Q32 Bio
  • GammaDelta Therapeutics
  • Tizona Therapeutics
  • Oxagen
  • SFJ Pharmaceuticals
  • Avedro
  • IFM Therapeutics
  • Virion Biotherapeutics
  • Realm Therapeutics
  • Pixium Vision

Social media:

Available after registration.